Jonathan Allan - 13 Aug 2025 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Signature
/s/ Jonathan Allan
Issuer symbol
STOK
Transactions as of
13 Aug 2025
Transactions value $
-$205,680
Form type
4
Filing time
15 Aug 2025, 16:31:44 UTC
Previous filing
20 Mar 2025
Next filing
18 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Allan Jonathan GENERAL COUNSEL & CORP SEC C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD /s/ Jonathan Allan 15 Aug 2025 0001966716

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Sale -$206K -13.7K -41.12% $15.00 19.6K 13 Aug 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.
F2 The reported total includes an aggregate 1,778 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d).